Skip to main content
Caplight Logo









Revolo Biotherapeutics

Revolo Biotherapeutics

Private
Gaithersburg, MarylandHealthcare & Life Scienceshttps://revolobio.com/

Last Round

Series B

Sep 21, 2020

Total Funding Raised

$62.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Revolo Biotherapeutics is a clinical-stage biotechnology company that develops therapies designed to reset the immune system to treat autoimmune and allergic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyautoimmune diseaseimmune-regulatory therapeuticpeptide-based therapeuticdrug developmentclinical trialsbiotechallergic diseaseimmune homeostasisdrug discoverybiopharmalicensing agreementcontract development and manufacturing organizationCDMO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Revolo Biotherapeutics Comparables

Compare Revolo Biotherapeutics with similar companies based on industry and business-model similarity.

Revolo Biotherapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
COUR Pharmaceuticals
83%
Anokion
81%
AbolerIS Pharma
81%

Revolo Biotherapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 21, 2020
VC RoundJun 30, 2018
Series AOct 11, 2017

Key People

Founding team and executive leadership

Woody Bryan

President And Chief Executive Officer

Executive Team

Revolo Biotherapeutics Investors

Notable investors and investment history

Revolo Biotherapeutics investors
InvestorRounds
Morningside VenturesSeries B
MetellusSeries B, VC Round, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 31% MoM, reaching 3.2K.

  • May 17, 2026

    Monthly visitors grew 192% MoM, reaching 2.4K.

Revolo Biotherapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Revolo Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Revolo Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersGaithersburg, Maryland
Employee Range19
Year Founded2011
Last FundingSep 21, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?